PreveCeutical Medical Inc. (18H.F)

0.0100 0.0000 (0.00%) At close: 08:02AM CEST

PreveCeutical Medical Inc.

885 Cambie Street
Suite 2500
Vancouver, BC V6B 0R6
Canada
604 416 7777
https://www.preveceutical.com

Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 

Description

PreveCeutical Medical Inc., a health sciences company, engages in the development of options for preventive and curative therapies utilizing organic and nature identical products. Its pipeline products include Cannabinoid Sol-Gel Delivery, a cannabinoid-based nose-to-brain delivery system that provides relief from various indications, including pain, inflammation, seizures, and neurological disorders; Non-Addictive Analgesic for pain management; BSV Peptide Program that targets cancer progression; and Dual Gene Therapy for type 2 diabetes and obesity. The company also develops a range of medicinal cannabis-based products. PreveCeutical Medical Inc. is headquartered in Vancouver, Canada.

Corporate governance

PreveCeutical Medical Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.